Quality of life and personality in essential tremor patients

Movement Disorders : Official Journal of the Movement Disorder Society
D LorenzG Deuschl

Abstract

The aim of this study was to determine the impact of essential tremor (ET) on quality of life and its relation with tremor severity and the personality profile of ET patients. One hundred and five patients with definite or probable ET from an outpatient population were tested with the Short-Form 36-Item Health Survey (SF36) and the Eysenck Personality Questionnaire (EPQ-R). Compared to controls, the ET patients scored worse in all eight domains of the SF36. The physical component score (PCS) did not differ significantly from the normal population, whereas ET patients older than 40 years were significantly more affected with regard to the mental domains measured by the mental component score (MCS) with their median below the 20th percentile of the German controls. Tremor severity correlated with some of the physical domains and the PCS as well as with social function of the mental domains. ET patients showed significantly lower scores in the psychoticism (P) scale of the EPQ-R, with a median value on the 11th percentile of normal German population, indicating a more tender-minded personality type. The MCS correlated highly significant with the neuroticism (N) scale and extraversion (E) scale of EPQ-R. Multiple regression analysi...Continue Reading

References

May 1, 1975·Psychological Medicine·K F Standage, G W Fenton
May 1, 1988·Psychological Medicine·M Jahanshahi, C D Marsden
Feb 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·C J Todes, A J Lees
Sep 1, 1996·Neurology·N BreslauP Andreski
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·G DeuschlM Brin
Dec 16, 1998·Journal of the Neurological Sciences·M J MooreP J Shaw
Aug 6, 2000·Archives of Neurology·E D LouisL F Barnes
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·A SchragN Quinn
Jun 20, 2001·The Journal of Clinical Psychiatry·F R SchneierE D Louis
Jul 5, 2001·Journal of Neurology·M GaspariniG Meco
Sep 12, 2001·Neurology·W J LombardiR E Gross
Jan 11, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·G-M HarizA T Bergenheim
Feb 15, 2002·Journal of the International Neuropsychological Society : JINS·Laura H LacritzC Munro Cullum
Mar 8, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A I TrösterW C Koller
Aug 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Anne FarmerPeter McGuffin
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Laura CamfieldUNKNOWN Epidemiological Study of Dystonia in Europe Collaborative Group
Feb 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·J A FieldsR Pahwa
Jun 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·A ChatterjeeE D Louis
Dec 21, 2004·Twin Research : the Official Journal of the International Society for Twin Studies·Nathan A GillespieNicholas G Martin

❮ Previous
Next ❯

Citations

Oct 14, 2009·Archives of Neurology·Elan D Louis
Apr 12, 2011·The Cerebellum·Hideto Miwa, Tomoyoshi Kondo
Dec 23, 2011·Parkinsonism & Related Disorders·Günther DeuschlHelge Hellriegel
Apr 14, 2011·Nature Reviews. Neurology·Félix Bermejo-Pareja
Feb 16, 2011·Seminars in Neurology·Andreas Puschmann, Zbigniew K Wszolek
Aug 16, 2013·The New England Journal of Medicine·W Jeffrey EliasMax Wintermark
Nov 6, 2009·Aging & Mental Health·Tatiana DubayovaJohan W Groothoff
Mar 11, 2008·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Steven Paul WoodsAlexander I Tröster
Aug 22, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E D LouisUNKNOWN Neurological Disorders in Central Spain (NEDICES) Study Group
Jan 20, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D LorenzG Deuschl
Aug 22, 2008·Neuroepidemiology·Elan D Louis
Sep 4, 2009·Paediatric Drugs·Joseph Ferrara, Joseph Jankovic
Oct 22, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Susanne A Schneider, Günther Deuschl
Dec 29, 2013·AJNR. American Journal of Neuroradiology·M WintermarkW J Elias
Nov 30, 2014·Neurologic Clinics·Susanne A Schneider, Günther Deuschl
Nov 24, 2011·Acta neurochirurgica·Ulrika SandvikPatric Blomstedt
Jun 5, 2012·Parkinsonism & Related Disorders·Giovanni FabbriniAlfredo Berardelli
May 17, 2011·Parkinsonism & Related Disorders·Dustin A HeldmanJoseph P Giuffrida
Dec 5, 2009·Journal of Clinical Epidemiology·Pablo Martínez-MartínJulián Benito-León
Sep 2, 2009·Journal of the Neurological Sciences·Elan D Louis
Apr 10, 2007·Lancet·Julián Benito-León, Elan D Louis
Sep 15, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Günther Deuschl, Rodger Elble
Sep 22, 2007·Acta Neurologica Scandinavica·H V NguyenD K Y Chan
Jun 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Elan D LouisUNKNOWN Neurological Disorders in Central Spain (NEDICES) Study Group
Nov 14, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Elan D Louis, Jean Paul G Vonsattel
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Rodger Elble, Günther Deuschl
Sep 28, 2010·Parkinsonism & Related Disorders·Rebecca E TraubElan D Louis
Oct 16, 2013·Parkinsonism & Related Disorders·C L PulliamD A Heldman
May 24, 2015·Parkinsonism & Related Disorders·Franziska HopfnerGregor Kuhlenbäumer
Feb 24, 2015·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Tony R WangW Jeff Elias
Jun 24, 2015·AJR. American Journal of Roentgenology·Pejman GhanouniMax Wintermark
Oct 4, 2011·Medical Hypotheses·A M Benis, D K Hobgood
Jun 19, 2012·Parkinsonism & Related Disorders·Mary Ann Thenganatt, Elan D Louis
Jul 10, 2012·Parkinsonism & Related Disorders·Vijay Chandran, Pramod Kumar Pal
Jan 6, 2012·Parkinsonism & Related Disorders·Vijay Chandran, Pramod Kumar Pal
Aug 25, 2016·The New England Journal of Medicine·W Jeffrey EliasJin W Chang
Mar 18, 2016·Arquivos de neuro-psiquiatria·Leonardo Mariano Inácio MedeirosVanderci Borges
Dec 8, 2016·Diseases of the Colon and Rectum·Tobias S SchiergensMichael S Kasparek
Nov 15, 2013·Therapeutic Advances in Neurological Disorders·Sarah C JanickiElan D Louis
May 26, 2017·IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·Jeffrey A HerronAndrew L Ko
Jul 11, 2007·Current Opinion in Neurology·Delia Lorenz, Günther Deuschl
Feb 7, 2018·Der Nervenarzt·G Deuschl, D Berg
Apr 12, 2019·Disability and Rehabilitation·Jessica MooreJane Simpson
Oct 20, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Robert Francis DallapiazzaAndres M Lozano
Jul 18, 2017·Movement Disorders Clinical Practice·Günther Deuschl
Sep 12, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Franziska Hopfner, Günther Deuschl
Jul 18, 2018·Frontiers in Neurology·Frederique M C BoonstraScott C Kolbe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.